Prostate carcinoma with peripheral metastases after prostatectomy and low levels of serum prostate specific antigen.
Seven
Bedri
B
Varoglu
Erhan
E
Cayir
Kerim
K
Sahin
Ali
A
Kantarci
Mecit
M
D000230:Adenocarcinoma / Q000097:blood* / Q000175:diagnosis / Q000601:surgery*; D000368:Aged; D015415:Biomarkers / Q000097:blood; D013196:Dihydrotestosterone / Q000097:blood; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000601:surgery*; D011863:Radioimmunoassay; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013739:Testosterone / Q000097:blood*; D016896:Treatment Outcome
D015415:Biomarkers; D013196:Dihydrotestosterone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017430:Prostate-Specific Antigen